title: Treatment of an atazanivir associated grade 4 hyperbilirubinaemia with efavirenz.
authors.forename: O
authors.initials: O
authors.lastname: Kummer
authors.forename: E
authors.initials: E
authors.lastname: Mossdorf
authors.forename: M
authors.initials: M
authors.lastname: Battegay
authors.forename: L
authors.initials: L
authors.lastname: Elzi
authors.forename: M
authors.initials: M
authors.lastname: Bodmer
authors.forename: S
authors.initials: S
authors.lastname: Krähenbühl
authors.forename: M
authors.initials: M
authors.lastname: Haschke
mesh_terms: D000480:Alkynes; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods; D000069446:Atazanavir Sulfate; D048588:Benzoxazines / Q000627:therapeutic use*; D003521:Cyclopropanes; D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006801:Humans; D006932:Hyperbilirubinemia / Q000139:chemically induced*; D008875:Middle Aged; D009842:Oligopeptides / Q000009:adverse effects*; D011725:Pyridines / Q000009:adverse effects*
chemical_list: D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D017320:HIV Protease Inhibitors; D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate; C098320:efavirenz